Indication

Anticholinergic toxicity

Anticholinergic toxicity is an acute toxic syndrome caused by the competitive antagonism of acetylcholine at central and peripheral muscarinic receptors. Read more about Anticholinergic toxicity

2 drugs 2 manufacturers

Advertisement

Drugs that treat it

Common Anticholinergic toxicity therapies.

Showing 1–2 of 2 drugs

Filter & compare in the drug finder →Opens the drug finder with Anticholinergic toxicity preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Anticholinergic toxicity.

Anticholinergic toxicity is an acute toxic syndrome caused by the competitive antagonism of acetylcholine at central and peripheral muscarinic receptors.

It typically affects the central nervous system and the autonomic nervous system across diverse patient populations, with older adults exhibiting heightened vulnerability due to age-related pharmacokinetic changes and polypharmacy.

Clinically, the toxidrome is defined by peripheral signs of parasympathetic blockade—including tachycardia, mydriasis, anhidrosis, hyperthermia, dry mucous membranes, urinary retention, and decreased bowel sounds—accompanied by central manifestations such as confusion, agitation, visual hallucinations, delirium, and potentially seizures or coma.

Personalize your experience

Follow Anticholinergic toxicity and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it